Latest Share Purchase Plan News

Page 15 of 97
WasteCo Group has initiated a $2 million share placement at $0.007 per share to fund its ambitious turnaround and growth strategy amid a FY 2026 loss. A Share Purchase Plan will follow, offering existing investors a chance to participate on the same terms.
Maxwell Dee
Maxwell Dee
2 Sept 2026
OMG Group has raised $1.5 million through a placement featuring a $350,000 strategic investment from Slades Beverages, which will become its oat milk manufacturing partner. The company plans a $250,000 Share Purchase Plan and director participation to fuel product launches and supply expansion following a 48% revenue surge in FY26.
Victor Sage
Victor Sage
2 Sept 2026
Argosy Minerals has raised $3 million through a placement at a 19% discount, with an additional $500,000 sought via a Share Purchase Plan to fund its 12ktpa Rincon Lithium Project development.
Maxwell Dee
Maxwell Dee
2 Sept 2026
GR Engineering Services launches a $10 million share purchase plan at the same price as a recent $100 million institutional placement, offering eligible shareholders a chance to invest up to $30,000 each.
Victor Sage
Victor Sage
2 Sept 2026
CurveBeam AI has secured over A$600,000 through its Share Purchase Plan, bolstering funds alongside a recent A$5 million placement. The capital will fuel the China launch and product development for its HiRise™ CT scanner.
Ada Torres
Ada Torres
1 Sept 2026
Sparc Technologies has made its inaugural commercial delivery of ecosparc®, a graphene additive, to a major coatings manufacturer, underpinning its push to dominate the protective coatings market. The company also launched a discounted Share Purchase Plan to fuel ongoing commercial expansion.
Victor Sage
Victor Sage
1 Sept 2026
Podium Minerals' recent share purchase plan secured $1.56 million, significantly below its $4 million underwritten target, leaving a $2.44 million shortfall to be addressed.
Maxwell Dee
Maxwell Dee
1 Sept 2026
Recce Pharmaceuticals narrowed its operating loss to AUD 15 million in FY26, progressing Phase 3 trials for its anti-infective RECCE 327 and securing key patents and commercial partnerships.
Ada Torres
Ada Torres
31 Aug 2026
NOVONIX Limited posted a $24.6 million half-year loss while delivering a critical synthetic graphite sample to Panasonic and reaffirming a 2027 production start. The company raised $21.7 million to fund its North American battery materials expansion amid ongoing U.S. trade and policy developments.
Maxwell Dee
Maxwell Dee
31 Aug 2026
Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.
Ada Torres
Ada Torres
31 Aug 2026
Cadence Opportunities Fund (ASX: CDO) is offering eligible shareholders a chance to buy up to $30,000 of shares at a 3.5% discount to market price, following a 30.3% portfolio gain for FY26 and a 41% total shareholder return.
Claire Turing
Claire Turing
31 Aug 2026
ClearVue Technologies saw a 35% revenue decline to $161,000 and a $11 million net loss in FY2026, driven by a major operational overhaul and significant product certification efforts. Despite the financial setback, the company expanded into new markets and secured key commercial projects.
Sophie Babbage
Sophie Babbage
31 Aug 2026

Browse the archive

Full archive